Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Guizzetti

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|June 15, 2016
Total versus partial splenectomy in pediatric hereditary spherocytosis: A systematic review and meta-analysisLeonardo Guizzetti
Pediatric Blood & Cancer|February 5, 2024
Temporal trends of splenectomy in pediatric hospitalizations with hereditary spherocytosis from 2000 to 2019: A national surveyLeonardo Guizzetti
Gastroenterology|June 23, 2019
Improving Clinical Trial Efficiency in GastroenterologyChristopher Ma, Leonardo Guizzetti, Vipul Jairath
The Journal of Endocrinology|February 19, 2013
The sorting of proglucagon to secretory granules is mediated by carboxypeptidase E and intrinsic sorting signalsRebecca McGirr, Leonardo Guizzetti, Savita Dhanvantari
The Journal of Biological Chemistry|April 15, 2014
Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathwayLeonardo Guizzetti, Rebecca McGirr, Savita Dhanvantari
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week DosingRocio Sedano, Leonardo Guizzetti, Cassandra McDonald, et al.
Crohn'S & Colitis 360|April 10, 2024
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study ParticipantsVirginia Solitano, Heather Prins, Meagan Archer, et al.
Gut|May 7, 2021
Methods for handling missing segments in Crohn's disease clinical trials: analysis from the EXTEND trialChristopher Ma, Reena Khanna, Leonardo Guizzetti, et al.
Statistics in Medicine|July 16, 2024
Extending the DeLong algorithm for comparing areas under correlated receiver operating characteristic curves with missing dataLily Zou, Yun-Hee Choi, Leonardo Guizzetti, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2019
No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control studyVipul Jairath, Suvi R K Hokkanen, Leonardo Guizzetti, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|June 15, 2016
Total versus partial splenectomy in pediatric hereditary spherocytosis: A systematic review and meta-analysisLeonardo Guizzetti
Pediatric Blood & Cancer|February 5, 2024
Temporal trends of splenectomy in pediatric hospitalizations with hereditary spherocytosis from 2000 to 2019: A national surveyLeonardo Guizzetti
Gastroenterology|June 23, 2019
Improving Clinical Trial Efficiency in GastroenterologyChristopher Ma, Leonardo Guizzetti, Vipul Jairath
The Journal of Endocrinology|February 19, 2013
The sorting of proglucagon to secretory granules is mediated by carboxypeptidase E and intrinsic sorting signalsRebecca McGirr, Leonardo Guizzetti, Savita Dhanvantari
The Journal of Biological Chemistry|April 15, 2014
Two dipolar α-helices within hormone-encoding regions of proglucagon are sorting signals to the regulated secretory pathwayLeonardo Guizzetti, Rebecca McGirr, Savita Dhanvantari
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week DosingRocio Sedano, Leonardo Guizzetti, Cassandra McDonald, et al.
Crohn'S & Colitis 360|April 10, 2024
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study ParticipantsVirginia Solitano, Heather Prins, Meagan Archer, et al.
Gut|May 7, 2021
Methods for handling missing segments in Crohn's disease clinical trials: analysis from the EXTEND trialChristopher Ma, Reena Khanna, Leonardo Guizzetti, et al.
Statistics in Medicine|July 16, 2024
Extending the DeLong algorithm for comparing areas under correlated receiver operating characteristic curves with missing dataLily Zou, Yun-Hee Choi, Leonardo Guizzetti, et al.
Alimentary Pharmacology & Therapeutics|July 13, 2019
No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control studyVipul Jairath, Suvi R K Hokkanen, Leonardo Guizzetti, et al.
Pageof 6